REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England (2021)

First Author: Ward H
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.02.26.21252512

Publication URI: http://dx.doi.org/10.1101/2021.02.26.21252512

Type: Preprint